Verily Life Sciences company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

verily.com

Executives

11

Board of Directors

2

Verily Life Sciences Board of Directors

2 Board of directors

Verily Life Sciences has 2 board of directors, including Kristian Marthinsen.

Name

Firm

Work History

Other Seats

Kristian Marthinsen

Verily Life Sciences

Kristina Saffran

Verily Life Sciences

Name

Kristian Marthinsen

Kristina Saffran

Firm

Work History

Other Seats

Verily Life Sciences

Verily Life Sciences

Verily Life Sciences Management Team

11 Team Members

Verily Life Sciences has 11 executives. Verily Life Sciences's founder is Vikram Bajaj. Verily Life Sciences's current President, Chief Operating Officer is Stephen Gillett.

Name

Work History

Title

Status

Vikram Bajaj

Founder

Current

Jessica Mega

Google, Harvard Medical School, Massachusetts General Hospital, and Brigham Health

Founder

Current

Thomas Stanis

Founder

Current

Stephen Gillett

President, Chief Operating Officer

Current

Vivian S Lee

President

Current

Name

Vikram Bajaj

Jessica Mega

Thomas Stanis

Stephen Gillett

Vivian S Lee

Work History

Google, Harvard Medical School, Massachusetts General Hospital, and Brigham Health

Title

Founder

Founder

Founder

President, Chief Operating Officer

President

Status

Current

Current

Current

Current

Current

You May Also Like

Cardionomic Logo
Cardionomic

Cardionomic addresses Acute Decompensated Heart Failure's root cause of reduced contractility. The therapy uses neuromodulation to benignly increase contractility, thus improving cardiac output therefore increasing renal flow and end organ perfusion. Benignly increasing contractility decreases negative hormonal signaling, and improves in-hospital morbidity/mortality.

N
Neuspera Medical

Neuspera Medical is a medical device startup that leverages exclusively licensed mid-field powering techniques to engineer miniaturized injectable neuromodulation technologies, sometimes referred to as electroceuticals. Neuspera's implantable module is more than 100 times smaller than other neuromodulation devices and may substantially reduce implant procedure complexity, time, patient complication, and post-surgical pain. Neuspera Medical is committed to bringing forward implantable medical device technology that will improve lives of patients battling with chronic illness.

S
ShiraTronics

ShiraTronics develops an approach to treat migraine headaches. The company is focused on developing and clinically testing its neuromodulation technology

SetPoint Medical Logo
SetPoint Medical

SetPoint Medical is developing a bioelectronic medicine platform using a small implanted device that activates the body's natural Inflammatory Reflex and produces a systemic anti-inflammatory effect.

L
LivaNova

LivaNova is a medical device company in the treatment of cardiovascular diseases. The company develops, manufactures, and markets medical technologies for cardiac surgery and for the treatment of cardiac rhythm disorders.

B
Brainsgate

BrainsGate develops a technology for modulation of cerebro-vascular properties through neuro-stimulation of the spheno-palatine ganglion. Affected properties are central to many CNS disorders - blood vessel permeability and blood flow. Currently targeted applications include treatment of ischemic stroke and drug delivery to the CNS through modifying the permeability of the blood brain barrier. The Company has initiated clinical trials, delivering a chemotherapeutic agent to primary brain tumor patients.)

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.